Monsanto Selects Locus' Cloud Software for Sustainability Management
News Jun 12, 2014
Monsanto Company, a leading global provider of technology-based solutions and agricultural products that improve farm productivity and food quality, has selected Locus Technologies (Locus) to provide a comprehensive, integrated software platform for sustainability management and environmental stewardship throughout the corporation's facilities.
Monsanto has adopted the Global Reporting Initiative (GRI) framework, a comprehensive sustainability reporting structure that is widely used around the world to more effectively measure, build upon, and communicate its current sustainability efforts. As a member of the GRI G4 Pioneers program Monsanto is utilizing the Locus enhanced data collection process to enable the transition to the new GRI G4 platform.
Locus' award-winning EH&S and sustainability software platform is already implemented and provides Monsanto with enterprise tools to organize the GRI indicator collection and reporting solution for its corporate sustainability group. Monsanto site personnel are now able to enter GRI Indicator data by site, and produce reports for their sites. Corporate personnel are able to produce reports of data aggregated across the entire organization for use in preparing and automating their GRI Reporting.
"We are very pleased that Monsanto has selected Locus' cloud-based software to organize its GRI information," said Neno Duplan, President and CEO of Locus Technologies. "The GRI Guidelines are the world's most widely-used sustainability reporting framework and we are very pleased to support Monsanto in their reporting requirements. Both Monsanto and Locus are GRI Organizational Stakeholders," added Duplan.
Scientists at Tokyo Tech, Ricoh co. and The National Institute of Advanced Industrial Science and Technology have developed an ultra-low-power atomic clock (ULPAC) for small satellites to enable future communication systems beyond 5G. The proposed device outperforms the current industry standards in various benchmarks, such as size, stability, and power consumption.
With their ability to treat a wide a variety of diseases, spherical nucleic acids are poised to revolutionize medicine. But before these digitally designed nanostructures can reach their full potential, researchers need to optimize their various components. A team has developed a direct route to optimize these particles, bringing them one step closer to becoming a viable treatment option for numerous diseases, including cancer.READ MORE